In vivo RNAi and CRISPR technologies to elucidate cancer driver, vulnerability and therapy resistance genes

Dr. Daniel Schramek, PhD
Principal Investigator, Lunenfeld-Tanenbaum Research Institute, Canadian Research Chair in Functional Cancer Genomics, Program in Systems Biology
Thursday, June 23, 2016 - 4:00pm
PMH, 610 University Avenue, 6th Floor Auditorium, Rm 6-604
Dr. Linda Pen
OCI Seminar Series